Evidence map›Paper›PMID 24681894›Full record

ReviewActa pharmacologica Sinica2014

Glutamate transporters in brain ischemia: to modulate or not?

Weronika Krzyżanowska, Bartosz Pomierny, Magłorzata Filip, Joanna Pera

Open access · bronzeAbstract readReview
In one paragraph

Review in Acta pharmacologica Sinica, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Review
  3. Plasma Cystine as a Marker of Acute Stroke Severity.Diagnostics (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Vitamin D3 and Ischemic Stroke: A Narrative Review.Antioxidants (Basel, Switzerland) · 2022
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Weronika KrzyżanowskaDepartment of Toxicology, Faculty of Pharmacy, Jagiellonian University, Medical College, Krakow, Poland.
Bartosz PomiernyDepartment of Toxicology, Faculty of Pharmacy, Jagiellonian University, Medical College, Krakow, Poland.
Magłorzata FilipDepartment of Toxicology, Faculty of Pharmacy, Jagiellonian University, Medical College, Krakow, Poland.
Joanna PeraDepartment of Neurology, Jagiellonian University, Medical College, Krakow, Poland.
Jagiellonian University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this review, we briefly describe glutamate (Glu) metabolism and its specific transports and receptors in the central nervous system (CNS). Thereafter, we focus on excitatory amino acid transporters, cystine/glutamate antiporters (system xc-) and vesicular glutamate transporters, specifically addressing their location and roles in CNS and the molecular mechanisms underlying the regulation of Glu transporters. We provide evidence from in vitro or in vivo studies concerning alterations in Glu transporter expression in response to hypoxia or ischemia, including limited human data that supports the role of Glu transporters in stroke patients. Moreover, the potential to induce brain tolerance to ischemia through modulation of the expression and/or activities of Glu transporters is also discussed. Finally we present strategies involving the application of ischemic preconditioning and pharmacological agents, eg β-lactam antibiotics, amitriptyline, riluzole and N-acetylcysteine, which result in the significant protection of nervous tissues against ischemia.

Indexed as

Ischemic PreconditioningAmino Acid Transport Systems, AcidicAnimalsBrainBrain IschemiaGlutamate Plasma Membrane Transport ProteinsGlutamic AcidHumansNeuroprotective AgentsSynaptic TransmissionTreatment OutcomeVesicular Glutamate Transport ProteinsAmino Acid Transport Systems, AcidicGlutamate Plasma Membrane Transport ProteinsGlutamic AcidNeuroprotective AgentsVesicular Glutamate Transport Proteins

Identifiers

PMID24681894
PMCPMC4813728
OpenAlexW1978553624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.